Selected research
Industry Research
Dry Powder Injectables Industry Research Report 2026
Market perspective
The global Dry Powder Injectables market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Dry Powder Injectables is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Dry Powder Injectables is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Dry Powder Injectables is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Dry Powder Injectables include Unison Chemical Works, Sakar Healthcare, Pace Biotech, Krosyl Pharma, Iskon Remedies, Flagship Biotech International Pvt Ltd, Cosmas Pharmacls, Captab Biotec and Bliss GVS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Dry Powder Injectables market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Dry Powder Injectables Market by Company
Unison Chemical Works
Sakar Healthcare
Pace Biotech
Krosyl Pharma
Iskon Remedies
Flagship Biotech International Pvt Ltd
Cosmas Pharmacls
Captab Biotec
Bliss GVS
Aqua Vitoe Lab
ANG Lifesciences
Dry Powder Injectables Segment by Type
Small Capacity:Below 10ml
Large Capacity:Above 10ml
Dry Powder Injectables Segment by Application
Healthcare
Cosmetic
Medical
Others
Dry Powder Injectables Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Powder Injectables market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dry Powder Injectables and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Powder Injectables.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Dry Powder Injectables manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Dry Powder Injectables by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Dry Powder Injectables in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Small Capacity:Below 10ml
- Large Capacity:Above 10ml
Applications
- Healthcare
- Cosmetic
- Medical
- Others
Companies covered
- Unison Chemical Works
- Sakar Healthcare
- Pace Biotech
- Krosyl Pharma
- Iskon Remedies
- Flagship Biotech International Pvt Ltd
- Cosmas Pharmacls
- Captab Biotec
- Bliss GVS
- Aqua Vitoe Lab
- ANG Lifesciences
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Dry Powder Injectables Market Size (2021-2032)
- 2.2.2 Global Dry Powder Injectables Sales (2021-2032)
- 2.2.3 Global Dry Powder Injectables Market Average Price (2021-2032)
- 2.3 Dry Powder Injectables by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Small Capacity:Below 10ml
- 2.3.3 Large Capacity:Above 10ml
- 2.4 Dry Powder Injectables by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Healthcare
- 2.4.3 Cosmetic
- 2.4.4 Medical
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Dry Powder Injectables Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Dry Powder Injectables Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Dry Powder Injectables Revenue of Manufacturers (2021-2026)
- 3.4 Global Dry Powder Injectables Average Price by Manufacturers (2021-2026)
- 3.5 Global Dry Powder Injectables Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Dry Powder Injectables, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Dry Powder Injectables, Product Type & Application
- 3.8 Global Manufacturers of Dry Powder Injectables, Established Date
- 3.9 Global Dry Powder Injectables Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Unison Chemical Works
- 4.1.1 Unison Chemical Works Company Information
- 4.1.2 Unison Chemical Works Business Overview
- 4.1.3 Unison Chemical Works Dry Powder Injectables Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Unison Chemical Works Dry Powder Injectables Product Portfolio
- 4.1.5 Unison Chemical Works Recent Developments
- 4.2 Sakar Healthcare
- 4.2.1 Sakar Healthcare Company Information
- 4.2.2 Sakar Healthcare Business Overview
- 4.2.3 Sakar Healthcare Dry Powder Injectables Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sakar Healthcare Dry Powder Injectables Product Portfolio
- 4.2.5 Sakar Healthcare Recent Developments
- 4.3 Pace Biotech
- 4.3.1 Pace Biotech Company Information
- 4.3.2 Pace Biotech Business Overview
- 4.3.3 Pace Biotech Dry Powder Injectables Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pace Biotech Dry Powder Injectables Product Portfolio
- 4.3.5 Pace Biotech Recent Developments
- 4.4 Krosyl Pharma
- 4.4.1 Krosyl Pharma Company Information
- 4.4.2 Krosyl Pharma Business Overview
- 4.4.3 Krosyl Pharma Dry Powder Injectables Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Krosyl Pharma Dry Powder Injectables Product Portfolio
- 4.4.5 Krosyl Pharma Recent Developments
- 4.5 Iskon Remedies
- 4.5.1 Iskon Remedies Company Information
- 4.5.2 Iskon Remedies Business Overview
- 4.5.3 Iskon Remedies Dry Powder Injectables Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Iskon Remedies Dry Powder Injectables Product Portfolio
- 4.5.5 Iskon Remedies Recent Developments
- 4.6 Flagship Biotech International Pvt Ltd
- 4.6.1 Flagship Biotech International Pvt Ltd Company Information
- 4.6.2 Flagship Biotech International Pvt Ltd Business Overview
- 4.6.3 Flagship Biotech International Pvt Ltd Dry Powder Injectables Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Flagship Biotech International Pvt Ltd Dry Powder Injectables Product Portfolio
- 4.6.5 Flagship Biotech International Pvt Ltd Recent Developments
- 4.7 Cosmas Pharmacls
- 4.7.1 Cosmas Pharmacls Company Information
- 4.7.2 Cosmas Pharmacls Business Overview
- 4.7.3 Cosmas Pharmacls Dry Powder Injectables Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Cosmas Pharmacls Dry Powder Injectables Product Portfolio
- 4.7.5 Cosmas Pharmacls Recent Developments
- 4.8 Captab Biotec
- 4.8.1 Captab Biotec Company Information
- 4.8.2 Captab Biotec Business Overview
- 4.8.3 Captab Biotec Dry Powder Injectables Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Captab Biotec Dry Powder Injectables Product Portfolio
- 4.8.5 Captab Biotec Recent Developments
- 4.9 Bliss GVS
- 4.9.1 Bliss GVS Company Information
- 4.9.2 Bliss GVS Business Overview
- 4.9.3 Bliss GVS Dry Powder Injectables Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Bliss GVS Dry Powder Injectables Product Portfolio
- 4.9.5 Bliss GVS Recent Developments
- 4.10 Aqua Vitoe Lab
- 4.10.1 Aqua Vitoe Lab Company Information
- 4.10.2 Aqua Vitoe Lab Business Overview
- 4.10.3 Aqua Vitoe Lab Dry Powder Injectables Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Aqua Vitoe Lab Dry Powder Injectables Product Portfolio
- 4.10.5 Aqua Vitoe Lab Recent Developments
- 4.11 ANG Lifesciences
- 4.11.1 ANG Lifesciences Company Information
- 4.11.2 ANG Lifesciences Business Overview
- 4.11.3 ANG Lifesciences Dry Powder Injectables Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 ANG Lifesciences Dry Powder Injectables Product Portfolio
- 4.11.5 ANG Lifesciences Recent Developments
5 Global Dry Powder Injectables Market Scenario by Region
- 5.1 Global Dry Powder Injectables Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Dry Powder Injectables Sales by Region: 2021-2032
- 5.2.1 Global Dry Powder Injectables Sales by Region: 2021-2026
- 5.2.2 Global Dry Powder Injectables Sales by Region: 2027-2032
- 5.3 Global Dry Powder Injectables Revenue by Region: 2021-2032
- 5.3.1 Global Dry Powder Injectables Revenue by Region: 2021-2026
- 5.3.2 Global Dry Powder Injectables Revenue by Region: 2027-2032
- 5.4 North America Dry Powder Injectables Market Facts & Figures by Country
- 5.4.1 North America Dry Powder Injectables Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Dry Powder Injectables Sales by Country (2021-2032)
- 5.4.3 North America Dry Powder Injectables Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Dry Powder Injectables Market Facts & Figures by Country
- 5.5.1 Europe Dry Powder Injectables Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Dry Powder Injectables Sales by Country (2021-2032)
- 5.5.3 Europe Dry Powder Injectables Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Dry Powder Injectables Market Facts & Figures by Country
- 5.6.1 Asia Pacific Dry Powder Injectables Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Dry Powder Injectables Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Dry Powder Injectables Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Dry Powder Injectables Market Facts & Figures by Country
- 5.7.1 South America Dry Powder Injectables Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Dry Powder Injectables Sales by Country (2021-2032)
- 5.7.3 South America Dry Powder Injectables Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Dry Powder Injectables Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Dry Powder Injectables Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Dry Powder Injectables Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Dry Powder Injectables Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Dry Powder Injectables Sales by Type (2021-2032)
- 6.1.1 Global Dry Powder Injectables Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Dry Powder Injectables Sales Market Share by Type (2021-2032)
- 6.2 Global Dry Powder Injectables Revenue by Type (2021-2032)
- 6.2.1 Global Dry Powder Injectables Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Dry Powder Injectables Revenue Market Share by Type (2021-2032)
- 6.3 Global Dry Powder Injectables Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Dry Powder Injectables Sales by Application (2021-2032)
- 7.1.1 Global Dry Powder Injectables Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Dry Powder Injectables Sales Market Share by Application (2021-2032)
- 7.2 Global Dry Powder Injectables Revenue by Application (2021-2032)
- 7.2.1 Global Dry Powder Injectables Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Dry Powder Injectables Revenue Market Share by Application (2021-2032)
- 7.3 Global Dry Powder Injectables Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Dry Powder Injectables Value Chain Analysis
- 8.1.1 Dry Powder Injectables Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Dry Powder Injectables Production Mode & Process
- 8.2 Dry Powder Injectables Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Dry Powder Injectables Distributors
- 8.2.3 Dry Powder Injectables Customers
9 Global Dry Powder Injectables Analyzing Market Dynamics
- 9.1 Dry Powder Injectables Industry Trends
- 9.2 Dry Powder Injectables Industry Drivers
- 9.3 Dry Powder Injectables Industry Opportunities and Challenges
- 9.4 Dry Powder Injectables Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst